Gamma's Takeover Gamble: New Broker Filings Show Bidders Are Still Sizing Up, Not Committing

Gamma is still in play, but the evidence still stops short of commitment

Gamma's public story remains a possible bid, not a confirmed transaction. The company may sound reassuring, but the disclosed evidence still points to a market that is sampling interest rather than locking in capital.

The deadline passed without a firm bid

On 24 June 2026, Epiris said there could be no certainty that any firm offer would be made, and it faced a subsequent deadline of 8 July 2026 to either announce a firm intention or say it did not intend to make an offer. Gamma later confirmed that discussions with the consortium are ongoing, while other potential offerors also remained in play. In takeover processes like this, the market usually responds to formal commitment, not possibility.

The broker filings show limited positioning

The latest Rule 8.5 disclosures do not suggest aggressive accumulation. Investec's filing shows 67,616 ordinary shares purchased and 67,616 sold, which is more consistent with balanced dealing than a bidder building one-way exposure. Goldman's filing, dated 27 July 2026, shows 1,480 securities owned and 5,393 short in Gamma. That is not, on its own, strong evidence of fresh institutional build-up or advanced bid preparation.

It is still reasonable to argue that intermediate filings do not tell the whole story. But until buyers show clearer balance-sheet commitment, this looks more like a process to monitor than a transaction that is effectively decided.

The public record still points to an option setup, not a resolved bid

Possible offer status keeps the story alive without confirming it

Gamma has been in an offer period since April, but the clearest live buyer signal is still described as a possible offer, not a firm intention. That distinction matters because a possible offer preserves upside speculation without fixing a clear outcome.

One earlier path also appears to have weakened. Oakley said it was not intending to make an offer, and the same announcement made clear that Giacom was not acting with Oakley. At the same time, Epiris remained in a process where no certainty had been given that any firm offer would be made. Taken together, that looks more like interest still being assessed than a near-term decided transaction.

Why that matters for near-term repricing

If a firm bid were closing into place, the public record would usually show steeper commitment. Instead, the key deadline produced an 8 July extension announcement, not a clean yes-or-no result. The broker evidence adds little more: Investec showed a matched block of 67,616 ordinary shares purchased and 67,616 sold, while Goldman's disclosed Gamma exposure remained small at 1,480 securities owned and 5,393 short.

That leaves two workable interpretations:

• Bull case: Gamma is still in an offer period with live possible-offer interest, so the setup still has speculative upside.
• Bear case: One counterparty has already stepped back, and the remaining path is still framed as uncertain, which makes a prompt, clean bid less likely.

On the current evidence, the more cautious reading is easier to defend.

What would actually change the market view

The setup is still live because Gamma is formally in an offer period, but live is not the same as committed.

Signals that would strengthen the bid case

• A Rule 2.7 firm intention announcement would be the clearest signal that a possible offer is becoming a real bid.
• Confirmation that the process is still structured rather than drifting would help. Until then, there is no certainty an offer will be made or what terms any offer might include.
• More decisive broker positioning would help too. For now, the clearest disclosed connection remains Epiris LLP-related exposure through Goldman, while Investec's filing still highlights client-serving capacity.

Signals that would weaken the bid case

• Another Rule 2.6 extension of PUSU deadline would suggest the process is still stalling.
• Further clarifications that interested parties are walking away would matter. Oakley already said it was not intending to make an offer.
• From the filings, the absence of new disclosures could also become a signal if it suggests the market is not moving closer to commitment.

The main risk either way

If the process loses momentum, the market is likely to stop underwriting the takeover narrative and re-rate Gamma more on standalone fundamentals.